REFERENCES
- Lundberg, L.G.; Lerner, R.; Sundelin, P.; Rogers, R.; Folkman, J.; Palmbad, J. Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity. Am J Pathol 2000, 157(1), 15–19.
- Steurer, M.; Zoller, H.; Augustin, F.; Fong, D.; Heiss, S.; Strasser-Weippl, K.; Gastl, G.; Tzankov, A. Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factor. Hum Pathol 2007, 38(7), 1057–1064.
- Ni, H.; Barosi, G.; Hoffman, R. Quantitative evaluation of bone marrow angiogenesis in idiopathic myelofibrosis. Am J Clin Pathol 2006, 126(2), 241–247.
- Klener, P. Some new findings in the pathogenesis of myeloproliferative disorders and new insight into more effective treatment Cas Lek Cesk 2006, 145(1), 4–8 (abstract).
- Aguiar Bujanda, D. Complete response of relapsed angioimmunoblastic T-cell lymphoma following therapy with bevacizumab. Letter to the editor. Ann Oncol 2008, 19(2), 396–397.